Keystone Symposia

This meeting took place in 2014

Here are the related meetings in 2021:
MEETING CHANGE TO VIRTUAL: Tumor Metabolism and the Microenvironment (A4)
Tumor Metabolism and the Microenvironment (EK14)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Tumor Metabolism (X6)

Organizer(s) William G. Kaelin, Jr., Benjamin F. Cravatt III and Peter K. Jackson
March 16—21, 2014
Whistler Conference Centre • Whistler, BC Canada
Discounted Abstract Deadline: Nov 18, 2013
Abstract Deadline: Dec 17, 2013
Scholarship Deadline: Nov 18, 2013
Discounted Registration Deadline: Jan 15, 2014

Sponsored by Bayer HealthCare Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited and TESARO, Inc. Supported by an educational donation provided by Amgen.

Summary of Meeting:
The recent discovery of mutations affecting metabolic enzymes such as succinate dehydrogenase, fumarate hydratase and isocitrate dehydrogenase provides genetic evidence that altered cellular metabolism can cause cancer. Moreover, it has become apparent that a number of proteins that regulate processes pertinent to cellular transformation, such as enzymes that affect chromatin structure, respond to specific cellular metabolites. Finally, technologies for monitoring cellular metabolism are improving rapidly including technologies that lend themselves to non-invasive imaging. The goals of this meeting are to bring together a diverse group of scientists from academia and industry with basic and translational interests surrounding cancer metabolism. A particular focus will be on metabolic enzymes as potential targets for treating and/or imaging cancer cells. Toward this end this meeting engages a diverse group of scientists including biologists, chemists and engineers. This meeting provides participants with a greater understanding of the language and logic of cellular metabolism and provides a sense of the translational opportunities emerging from our growing knowledge of the role that altered metabolism plays in cancer.

View Meeting Program


National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Talya L. Dayton
Massachusetts Institute of Technology, USA

Christopher Thomas Hensley
University of Texas Southwestern Medical Center, USA

National Cancer Institute (NCI) Scholarship Recipients

Ohman Kwon
Korea Research Institute of Bioscience and Biotechnology, South Korea

Caroline Lewis
Massachusetts Institute of Technology, USA

Yoav D. Shaul
Hebrew University-Hadassah Medical School, Israel

The Elkes Foundation Scholarship Recipients

Vanessa A. Damoulis
The Scripps Research Institute, USA

Melinda Michele Mulvihill
University of California, Berkeley, USA